/People

Jennifer A. Doudna

Investor

iPartner at The Column Group

Find your path to Jennifer

Sign up to see every warm intro you have to Jennifer

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Jennifer. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

A UC Berkeley biochemist who co-developed CRISPR-Cas9 gene editing, earning the 2020 Nobel Prize in Chemistry. Founder and President of the Innovative Genomics Institute.

Colleagues at The Column Group

Frequently asked questions

Who is Jennifer A. Doudna?
A UC Berkeley biochemist who co-developed CRISPR-Cas9 gene editing, earning the 2020 Nobel Prize in Chemistry. Founder and President of the Innovative Genomics Institute.
Where does Jennifer A. Doudna work?
Jennifer A. Doudna is iPartner at The Column Group.

About this profile. Compiled from public sources — The Column Group's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights